European Pharmaceutical Review

NOVEMBER 24, 2022

One area in which the problem can be tackled effectively is product packaging. With predictions that the global market for anticounterfeiting packaging is set to reach almost $250 billion by 2026, growth in authentication and anti-tamper devices such as holograms appear to have a healthy future.”

Packaging 111

Packaging Labelling Documentation Dosage 111

European Pharmaceutical Review

AUGUST 17, 2022

The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and commercial drug products.

Pharmaceutical Manufacturing 96

Pharmaceutical Manufacturing Dosage Packaging Labelling 96

European Pharmaceutical Review

SEPTEMBER 26, 2023

The regulatory package submitted to the EC included evidence derived extensive analytical characterisation. Tyruko ® has the same strength/dosage form, intravenous (IV) route of administration, dosing regimen and presentation as the reference medicine, according to Sandoz. The site is planned to be completed by 2026.

Biosimilars 59

Biosimilars Dosage Packaging 59